Related Experiment Video
Updated: Aug 28, 2025

12:10
Semi-automated Optical Heartbeat Analysis of Small Hearts
Published on: September 16, 2009
12.3K
Assessing the Impact of the American Heart Association's Research Portfolio: A Scientific Statement From the American
Circulation
|September 22, 2022
Summary
The American Heart Association
Area of Science:
- Cardiovascular research
- Research funding evaluation
- Scientific career development
Background:
- The American Heart Association (AHA) Research Committee established performance metrics to evaluate its research portfolio.
- This report assesses the AHA's research program progress from 2008 to 2017.
- Evaluating research impact is crucial for strategic goal achievement.
Purpose of the Study:
- To measure the performance and outcomes of the AHA's research portfolio.
- To assess the impact of AHA funding on researcher career progress and scientific output.
Main Methods:
- Bibliometric analysis (publication tracking and impact).
- Career development measures (subsequent funding, IP, appointments).
- Post-award surveys of fellowship and grant recipients.
Main Results:
- AHA awardee publications showed high bibliometric impact (Field-Weighted Citation Index 1.5-3.0).
- Publication rates correlated with career stage (0.5-4/year).
- High career success rates: 72% of fellows secured research positions, 45% of grant awardees received promotions, and 83% secured further funding.
Conclusions:
- AHA funding positively impacts researcher careers and scientific output.
- Performance metrics demonstrate the AHA's commitment to high-quality, impactful research.
- Continuous evaluation ensures the AHA research program meets its strategic objectives.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
489
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
489
Anatomy of the Heart
110.2K
The human heart is made up of three layers of tissue that are surrounded by the pericardium, a membrane that protects and confines the heart. The outermost layer, closest to the pericardium, is the epicardium. The pericardial cavity separates the pericardium from the epicardium. Beneath the epicardium is the myocardium, the middle layer, and the endocardium, the innermost layer. There are four chambers of the heart: the right atrium, the right ventricle, the left atrium, and the left ventricle.
110.2K
Heart Failure Drugs: β-Blockers
418
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
418
Heart Failure II: Pathophysiology
31
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31
Ischemic Heart Disease: Overview
1.4K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
Pathophysiology of Heart Failure
1.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K

